All In Biotech

Free tool

FAERS Monitor: Asmanex Hfa

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205641 or its brand name (Asmanex Hfa, Mometasone Furoate). Reports on generic versions are filed under their own applications.

Reports

11,481

Serious

7,460

65% of reports

Hospitalization

3,247

Death reported

505

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea1,099
  • drug ineffective968
  • asthma945
  • headache934
  • cough818
  • off label use797
  • fatigue700
  • pruritus652
  • gastrooesophageal reflux disease603
  • wheezing579
  • nausea578
  • hypersensitivity566
  • pain552
  • no adverse event548
  • pneumonia533

Reports by year received

View as table
YearReports
200457
200556
200656
200791
2008150
2009122
2010145
2011143
2012145
201396
2014139
2015225
2016382
2017424
2018897
2019876
2020840
20211,051
20221,262
20231,238
20241,058
20251,079
2026949

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,678 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
wheezingSignal57918.116.79,245
asthmaSignal94515.414.512,709
gastrooesophageal reflux diseaseSignal60313.812.87,131
hypersensitivitySignal5665.65.22,147
no adverse eventSignal5485.65.12,054
coughSignal8185.45.02,924
dyspnoeaSignal1,0993.63.42,074
pruritusSignal6523.12.9948
pneumoniaSignal5333.02.8728
headacheSignal9342.72.61,053
off label use7971.71.6222
fatigue7001.61.5184
pain5521.61.5144
drug ineffective9681.31.391
nausea5781.31.251

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.